Clinical Trial Update: Lorazepam for Delirium Prevention in Critically Ill Patients With High Anttila-Index [Phase 4]

View source ↗

Summary

This clinical trials update describes a Phase 4 study evaluating lorazepam for delirium prevention in critically ill patients with a high Anttila-Index. The tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Lorazepam (Lorazepam)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Delirium Confusional State | Phase 4 | Status: NOT_YET_RECRUITING